海外の治験の状況「1」での検索結果
8300件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA)
- Advanced Gastric Cancer
- China
- 2017-07-18
Recruiting
- Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer
- Gastric Cancer;Apatinib;Biomarker;Gastric Cancer;Apatinib;Biomarker;Gastric Cancer;Apatinib;Biomarker;Gastric Cancer;Apatinib;Biomarker
- China
- 2017-07-13
Recruiting
- A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC
- Non-Small Cell Lung Cancer
- Argentina, Australia, Belgium, Brazil, Canada, Chile, China, France, Germany, Ireland, Italy, Japan, Mexico, Poland, Romania, Russian Federation, Spain, United Kingdom, United States
- 2017-07-11
Recruiting
- The Exploration of the Efficacy of Metformin Combined with First-line Chemotherapy for the Treatment of Ovarian Cancer
- ovarian cancer
- China
- 2017-07-04
Recruiting
- First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS
- Metastatic Colorectal Cancer
- Italy
- 2017-07-03
Recruiting
- A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)
- Small Cell Lung Cancer
- Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, China, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2017-01-25
Recruiting
- Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia
- Acute Leukemia (Category)
- Belgium, France, Germany, Greece, Israel, Italy, Lithuania, Portugal, Spain, United States
- 2009-06-03
Recruiting
- CPR Education: Traditional Program Versus On-line Program
- Cardiopulmonary Resuscitation
- Taiwan
- 2018-06-28
Recruiting
- A Phase 3 Comparison of Platinum-Based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
- Ovarian Cancer
- Belgium, Canada, Czechia, Denmark, Finland, France, Romania, Spain, United States
- 2018-06-28
Recruiting
- Effect of Extended Infusion Lines on Pulse Contour-based Measurements
- Hemodynamic Instability
- Belgium
- 2018-06-20
Recruiting
- Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer
- Stage III Breast Cancer;Stage IIIA Breast Cancer;Stage IIIB Breast Cancer;Stage IIIC Breast Cancer;Stage IV Breast Cancer;Estrogen Receptor-positive;HER2/Neu Negative
- United States
- 2018-06-11
Recruiting
- Study Maintenance Regorafenib vs Placebo, no Progression Patients After I Line Chemotherapy Metastatic Gastric Cancer
- Gastric Cancer
- Italy
- 2018-05-18
Recruiting
- Raltitrexed-based chemotherapy as second-line treatment in advanced colorectal cancer: a prospective, multi-center, non-intervention registration study
- Colorectal Cancer
- China
- 2018-05-17
Recruiting
- Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line Treatment
- Leiomyosarcoma Metastatic
- Korea, Republic of
- 2018-05-10
Recruiting
- Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer
- Colorectal Cancer
- Germany
- 2018-05-08
Recruiting
- Malutiple-institutional observational surveillance of Pembrolizumab as a first line treatment for non-small cell lung cancer
- non small cell lung cancer
- Japan
- 2018-05-04
Recruiting
- A Study of Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer
- Extensive-stage Small Cell Lung Cancer
- China
- 2018-04-23
Recruiting
- XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer
- Colorectal Neoplasms;Chemotherapy;Colorectal Neoplasms;Chemotherapy;Colorectal Neoplasms;Chemotherapy
- China
- 2018-04-18
Recruiting
- Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC
- Lung Cancer
- Spain
- 2018-04-17
Recruiting
- Pembrolizumab (MK-3475) as First-line Therapy for High Risk T1 Non-Muscle-Invasive Bladder Cancer
- Bladder Cancer
- United States
- 2018-04-11